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Treatment Standards for
Acute Infarction
Improving Door-to-Balloon Times
Improving door to balloon times for patients with ST-segment elevationmyocardialinfarction (STEMI) can significantly improve outcomes, but many facilities often
exceed the recommended 90-min guideline. Bradley and colleagues studied 11 hospi-
tals that have been able to consistently achieve the 90 min recommendation to
determine the best practices for achieving this goal. They describe several critical
innovations; the most effective appears to be prehospital electrocardiograms with
prompt activation of the catheterization laboratory by emergency department physi-
cians. Interdisciplinary collaboration and the adoption of explicit strategies for over-
coming institutional inertia are required to consistently achieve the 90-min guideline.
See page 1236. See figure.
Treatment Standards for
Acute Infarction
Adherence to Guidelines Leads to Mortality Improvements
TheGuidelines Applied in Practice (GAP) Project is one of several initiatives thatseek to improve the quality of healthcare through the use of standardized,
evidence-based protocols. Demonstration of a mortality benefit has not previously
beendone. Eagle and colleagues compared the care delivered and themortality rates for
acute myocardial infarction before and after implementation of the GAP project at
several hospitals.Mortalitywas improved at all three time intervals studied,with a 21%
to 26% relative reduction. The mortality benefit was greatest when a disease specific
discharge tool was used; this form, signed by the patient and the physician, details the
medications prescribed and the plan for future follow-up. This study lends support to
the burgeoningmovement to link reimbursement to qualitymeasures by showing that
these measures can improve mortality. See page 1242.
Chronic Coronary Disease
Only Large Areas of Viable, Non-Perfused Myocardium Increase Risk
Revascularization improves survival in patients with ischemic cardiomyopathy, butthere remains uncertainty in determining which patients will derive the greatest
benefit. Positron emission tomography (PET) is able to accurately measure both
myocardial perfusion (using ammonia as the tracer) and myocardial viability (using
uptake of glucose). Desideri and colleagues report on the results of nearly 200 subjects
with ischemic cardiomyopathy who underwent PET scanning but did not undergo
revascularization for a variety of reasons. Small areas of viable, non-perfused myocar-
diumdidnot affect survival, but those subjects inwhich20%of themyocardiumwas
viable but not perfused had significantly decreased survival. This suggests that in
patients with co-morbid conditions that increase the risk of revascularization, a cut-off
of 20%viable, non-perfusedmyocardiummay serve as an important risk stratifier.See
page 1264.
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Chest Pain and
Normal Coronaries
Etiology of Chest Pain in Patients With Normal Angiograms
Many patients with classical angina-like chest pain have angiographically normalcoronary arteries; the etiology of this pain is unknown.Madaric and colleagues
hypothesized that these patients might have an over-vigorous response to adrenergic
stimulation. They tested this by performing dobutamine echocardiography with spe-
cial attention to the appearance of elevated intraventricular flow velocities (IFV)
suggesting dynamic outflow tract obstructions. No patient had inducible wall motion
abnormalities, and all had normal resting echocardiograms, but one-half did develop
IFV 3 m/s with dobutamine. Chronic treatment with a beta-blocker reduced the
frequency of angina like pain and the inducible IFV. This study suggests that some
patients may develop increased wall stress and dynamic outflow tract obstruction in
response to physiologic increases in adrenergic stimulation; this may be the etiology of
their chest pain. See page 1270. See figure.
Heart Rhythm Disorders
Elevated CRP Levels Predict AF Recurrence
Predicting which patients will remain in normal sinus rhythm after cardioversionfrom atrial fibrillation (AF) is difficult. There is histologic evidence that suggests
that inflammationmay contribute to the development, ormaintenance, of AF.Malouf
and colleagues measured pre-cardioversion C-reactive protein (CRP) levels in patients
referred for cardioversion and followed them for reversions.Arrhythmia recurrencewas
associated with significantly higher pre-cardioversion CRP levels, and was the only
independent predictor of AF recurrence. These data suggests that high CRP levels are
associated with an increased risk of AF recurrence and support the hypothesis that
anti-inflammatory interventionsmay help tomaintain normal sinus rhythm after CV.
See page 1284.
